Idarucizumab (Praxbind): The First Reversal Agent for a Direct Oral Anticoagulant
- Am J Med. 2017 May;130(5):e195-e197. doi: 10.1016/j.amjmed.2016.11.029.
Affiliations
- 1. Clinical Pharmacy, University of Tennessee College of Pharmacy, Memphis.
PMID: 28011314
DOI: 10.1016/j.amjmed.2016.11.029
Products
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: ThrombinResearch Areas: Cardiovascular Disease